Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. Nie
FDA Approval: Siltuximab for the Treatment of Patients With Multicentric Castleman Disease
Clinical Cancer Research
Cancer Research
Oncology
Atherosclerosis Plaque Heterogeneity and Response to Therapy Detected by in Vivo Molecular Imaging of Matrix Metalloproteinase Activation
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Related publications
Siltuximab: A Targeted Therapy for Idiopathic Multicentric Castleman Disease
Immunotherapy
Oncology
Allergy
Immunology
Biologic Agents in the Treatment of Multicentric Castleman Disease
Turkish Thoracic Journal
Pulmonary
Respiratory Medicine
Long-Term Safety of Siltuximab in Patients With Idiopathic Multicentric Castleman Disease: A Prespecified, Open-Label, Extension Analysis of Two Trials
The Lancet Haematology
Hematology
Clinicopathologic Characteristics of 342 Patients With Multicentric Castleman Disease in Japan
Modern Rheumatology
Medicine
Rheumatology
Multicentric Castleman Disease: An Unusual Breast Lump
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Predictors of Response to Anti-Il6 Monoclonal Antibody Therapy (Siltuximab) in Idiopathic Multicentric Castleman Disease: Secondary Analyses of Phase II Clinical Trial Data
British Journal of Haematology
Hematology
FDA Approval: Blinatumomab for Patients With B-Cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission With Minimal Residual Disease
Clinical Cancer Research
Cancer Research
Oncology
Multicentric Castleman' S Disease Manifesting in the Lung: Clinical, Radiographic, and Pathologic Findings and Successful Treatment With Corticosteroid and Cyclophosphamide.
Internal Medicine
Internal Medicine
Medicine
FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
